Schedule 13G/A Filing by Integrated Core Strategies (US) LLC and Others for Astria Therapeutics, Inc.

Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed an amendment to their Schedule 13G for Astria Therapeutics, Inc. The filing indicates that these entities collectively own a significant portion of the company's common stock. Integrated Core Strategies (US) LLC reports owning 0.3% of the shares, while Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each report owning 0.4% of the shares. The filing is made under Rule 13d-1(c) and includes a joint filing agreement among the entities. The purpose of the filing is to disclose their beneficial ownership and to confirm that the securities were not acquired for the purpose of influencing the control of the issuer.